The Evidence and Clinical Rationale for the Use of JAK Inhibitors in the Management of AD . Can Allergy Immunol Today [Internet]. 12 nov. 2022 [cité 20 mars 2026];2(s11):3–11. Disponible à: https://canadianallergyandimmunologytoday.com/article/view/2-s11-lacuesta_and_lee